HC Surgical Specialists Limited (SGX:1B1)

Singapore · Delayed Price · Currency is SGD

0.3500

0.00 (0.00%)

At close: Sep 7, 2026

Market Cap	53.68M +6.1%
Revenue (ttm)	19.73M +2.2%
Net Income	6.98M -17.2%
EPS	0.05 -17.1%
Shares Out	153.38M
PE Ratio	7.69
Forward PE	n/a
Dividend	0.02 (5.94%)
Ex-Dividend Date	Mar 2, 2026

Volume	12,300
Open	0.3550
Previous Close	0.3500
Day's Range	0.3500 - 0.3550
52-Week Range	0.3250 - 0.4000
Beta	-0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 5, 2026

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g... [Read more]

Industry Offices and Clinics of Doctors of Medicine

Founded 2015

Country Singapore

Stock Exchange Singapore Exchange - Catalist

Ticker Symbol 1B1

Full Company Profile

Financial Performance

In fiscal year 2026, HC Surgical Specialists's revenue was 19.73 million, an increase of 2.22% compared to the previous year's 19.30 million. Earnings were 6.98 million, a decrease of -17.24%.

Financial Statements